Exceptionally rare, sarcomas are diagnosed in less than 1,300 children and adolescents in the U.S. annually – roughly half with Ewing sarcoma or osteosarcoma and the remaining with soft tissue sarcomas (rhabdomyosarcoma and nonrhabdomyosarcoma soft tissue sarcoma). The 35 to
40 children who enter the Gill Center’s Sarcoma Program each year receive care from national leaders in sarcoma treatment and research.
An interdisciplinary team of specialists and subspecialists meets monthly to develop treatment plans for newly diagnosed patients, patients in relapse and patients whose care is at complex decision- making junctures. The team includes pediatric oncologists, orthopaedic oncology surgeons, radiologists, pathologists, a nurse practitioner, nurses, psychologists, physical and occupational therapists, and prosthetists from both UT Southwestern and Texas Scottish Rite Hospital for Children. Individually and collectively, the team translates the latest sarcoma research into the best possible care for patients.
- Internationally recognized leaders in sarcoma research
- Long-standing collaboration with the Prosthetics Department at Texas Scottish Rite Hospital for Children
- Innovative use of CT PET scans to evaluate for metastatic disease, identifying targets for therapy
- Active enrollment of all newly diagnosed patients in clinical studies sponsored by the National Cancer Institute, the Children’s Oncology Group and UT Southwestern
- Active enrollment of newly diagnosed patients to CPRIT-sponsored study to develop molecularly driven personalized therapies in sarcoma